A feasibility study of adjuvant therapy with UFT/Leucovorin+Oxaliplatin following curative resection for stage III colorectal cancer
Phase 2
Recruiting
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000016007
- Lead Sponsor
- Gunma University Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Not provided
Exclusion Criteria
1. Multiple malignancies within five years 2. Serious complications 3. Peripheral neuropathy 4.Serious diarrhea 5. Serious drug allergy 6. Positive for HBs antigen and HCV antibody 7. Women who are pregnant, lactating, or wish to become pregnant 8. Any other cases who are regarded as inadequate for study enrollment by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment completion ratio
- Secondary Outcome Measures
Name Time Method Disease free survival(DFS) Overall Survival (OS) Safety profile